|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SPACELABS MEDICAL INC, 10-Q, EX-10.44, 2000-08-14 |
Next: LIGAND PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUL-01-2000
<CASH> 3,603
<SECURITIES> 0
<RECEIVABLES> 62,941
<ALLOWANCES> 3,233
<INVENTORY> 85,709
<CURRENT-ASSETS> 180,694
<PP&E> 135,077
<DEPRECIATION> 73,096
<TOTAL-ASSETS> 277,466
<CURRENT-LIABILITIES> 53,879
<BONDS> 66,675
0
0
<COMMON> 113
<OTHER-SE> 162,820
<TOTAL-LIABILITY-AND-EQUITY> 277,466
<SALES> 119,120
<TOTAL-REVENUES> 119,120
<CGS> 68,808
<TOTAL-COSTS> 68,808
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 481
<INTEREST-EXPENSE> 2,678
<INCOME-PRETAX> (9,682)
<INCOME-TAX> (3,511)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,171)
<EPS-BASIC> (0.65)
<EPS-DILUTED> (0.65)
</TABLE>
|
|